Trials / Unknown
UnknownNCT04101500
Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD).
Clinical Study on the Efficacy of Compound Sodium Chlorate and Aminophylline Tablets for Mild to Moderate Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD).
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an important event in the management of chronic obstructive pulmonary disease. Compound sodium chlolate and aminophylline tablets are one of the most widely used drugs for the treatment of bronchial asthma and chronic bronchitis.
Detailed description
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an unignorable event in the management of chronic obstructive pulmonary disease. It is crucial to seek for effective management strategy. Compound sodium chlolate and aminophylline tablets are one of the most widely used drugs for the treatment of bronchial asthma and chronic bronchitis. Compared with the local bronchodilator recommended by the guidelines, it has the advantages of convenient use and good patient compliance. For the purpose of optimize the management of acute exacerbation of chronic obstructive pulmonary disease and provide more convenient options, we compared the efficacy of combined compound sodium chlolate and aminophylline tablets with nebulized ipratropium bromide inhalation plus systemic glucocorticoids in the treatment of chronic obstructive pulmonary disease ranging from moderate degree to severe degree. We hope this research would benefit patients with chronic obstructive pulmonary, especially those in the grassroots.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Compound Ipratropium Bromide Solution(C1) for Inhalation | The patient's condition and basic condition were the same in the experimental group and the control group. |
| DRUG | Compound Sodium Chlolate and Aminophylline Tablets(C2) | Applied only to the experimental group. |
| DRUG | Placebo Tablets | Applied only to the control group. |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2020-12-30
- Completion
- 2024-12-30
- First posted
- 2019-09-24
- Last updated
- 2019-09-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04101500. Inclusion in this directory is not an endorsement.